Cintia Piccina - Chief Commercial Officer at Kalaris Therapeutics, Inc.

Issuer-level insider activity

Identity Names, identifiers, and filing context for this profile. 1 identity field
Entity type
Individual
Source evidence Original filing metadata and source links for verification. 1 source field
Source filing history
Open source filing history

No buys or sells have been reported by Cintia Piccina since 14 Aug 2025

Reported holdings for Cintia Piccina in Kalaris Therapeutics, Inc.

Form 4 holding Chief Commercial Officer

Allovir, Inc.

Security class
Common Stock
Shares / value
147,000
Estimated value
$98,608
Report date
03 Jul 2023
Price
$0.6708
Ownership
Direct
Form 4 holding Chief Commercial Officer

Allovir, Inc.

Security class
Stock Option (Right to Buy)
Shares / value
273,000
Estimated value
Report date
03 Jul 2023
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount

Transaction history for Cintia Piccina in Kalaris Therapeutics, Inc.

Sym Class Transaction % SEC-reported value SEC-reported price Shares Shares after Date Ownership
* marks a reported price that did not pass the local price check.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .